Matthew K. Fust - 04 Mar 2022 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role: Director
Signature: /s/ Karah Parschauer, attorney-in-fact
Issuer symbol: RARE
Transactions as of: 04 Mar 2022
Net transactions value: +$302,775
Form type: 4
Filing time: 08 Mar 2022, 11:25:01 UTC
Previous filing: 05 Nov 2021
Next filing: 21 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RARE	Common Stock	Options Exercise	$302,775	+7,500	+48%	$40.37	23,195	04 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RARE	Stock Option (Right to Buy)	Options Exercise	$0	-7,500	-100%	$0.000000^*	0	04 Mar 2022	Common Stock	7,500	$40.37	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
F2	The option vested in full on on June 18, 2015.